Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 BioInvent Inks Mfg. Pact with Global Pharma Firm | Contract Pharma

What are you searching for?

Sign in
Breaking News

BioInvent Inks Mfg. Pact with Global Pharma Firm

Contract is valued at SEK 8 million

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

BioInvent International has signed an extended contract for manufacturing services with a top global pharmaceutical client for one of its development products. Product details and services were not disclosed. The new agreement is expected to generate about SEK 8 million in revenue, with the majority occurring in 2016. Michael Oredsson, president and chief executive officer of BioInvent, said, “We are pleased that we have been contracted to provide additional manufacturing services to this major global pharmaceutical client. The extension of our relationship reflects BioInvent’s world-leading expertise in antibody production based around our cGMP-certified facilities, which meet EU and standards.” BioInvent has recently enhanced its ability to independently produce antibodies following the investment in a single use bioreactor for the development of internal and external projects. BioInvent’s production facility has the capacity to produce antibodies,both for research purposes and for clinical trials through to Phase III.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters